Upgrade

bioAffinity Technologies, Inc.

BIAFW

Last
$0.57
Day
+39.0%
1y
-58.3%
5y
-80.5%
52w
-63.2%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.35
EMA 50
0.29
EMA 200
0.32
20d high
-58.3%
5y high
-90.9%
5y range
9th
Website · 57 employees · United States

Positions held

Your positions

BIAFW isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
41
Hold
swing
Signal
Strong Buy
Target
$0.71
Stop
$0.16
Stop distance
71.8%
Target vs last
+25.2%

Fundamentals

Market cap—Enterprise value—Trailing P/E—Forward P/E—
PEG—Price / book0.05Beta-1.25Dividend yield—
Revenue growth19.0%Earnings growth—Gross margin34.6%Operating margin-2.2%
Profit margin-2.6%ROE-18.6%ROA-125.1%Debt / equity0.38
Current ratio1.44Free cash flow-$6.91MAnalyst recommendationnoneMean target—
52w high$0.6052w low$0.41

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q2
Revenue$1.5M$1.4M$1.5M$1.4M$1.3M
Op margin-220.8%-267.6%-207.4%-158.6%-198.2%
Net income-$3.4M-$3.6M-$3.1M-$5.1M-$4.1M
Gross margin28.0%31.3%41.5%34.8%19.9%
Gross profit$0.4M$0.4M$0.6M$0.5M$0.3M
Operating income-$3.3M-$3.6M-$3.2M-$2.3M-$2.5M
  • Revenue +12% vs prior quarter ($1.5M vs $1.4M).
  • Gross margin 28% (was 31.3% prior quarter).
  • Operating margin expanded to -220.8%.

Yearly (6y)

20252024202320222021
Revenue$6.1M$9.4M$2.5M$0.0M—
Op margin-174.0%-95.6%-314.8%-83511.5%—
Net income-$14.9M-$9.0M-$7.9M-$8.2M—
Gross margin30.8%36.1%31.3%90.3%—
Gross profit$1.9M$3.4M$0.8M$0.0M—
Operating income-$10.6M-$9.0M-$8.0M-$4.0M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

No headlines.

BIAFW · daily+214.6% over 14 sessions
Close EMA21 EMA50 EMA200
0.100.270.430.600.762026-092026-092026-092026-092026-092026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$5M-$3M-$2M-$0M$2M-268%-113%42%2025-Q22025-Q32025-Q42026-Q12026-Q2